Ischemia-reperfusion injury (IRI) plays a major role in many clinical conditions, including shock, stroke, myocardial infarction, and solid organ transplantation. Kidney IRI is the major cause of ischemic acute renal failure (ARF) in the native and transplanted kidney. It is currently unclear why allografts with significant IRI have a higher incidence of acute rejection and poor long-term graft function. [1] [2] [3] The pathogenesis of kidney IRI is complex and only partially understood. The role of inflammation in IRI has been increasingly appreciated, with involvement of leukocytes, adhesion molecules, chemokines, and cytokines. Recent studies from a number of different laboratories have demonstrated that T cells can directly mediate postischemic injury in the kidney [4] [5] [6] [7] as well as extra-renal organs such as liver, intestine, and lung. [8] [9] [10] CD4 T cells appear to be the major T cells involved in IRI, 5, 11 and the Th1 phenotype is deleterious. 12, 13 Despite convincing data from different groups that T cells participate in the pathogenesis of IRI, there is little information on the underlying mechanisms. One important question is whether the T-cell receptor (TCR) is involved in IRI. Evidence for the participation of the TCR in IRI would be important to direct future research into 'classical' pathways to study the T cell, as early T-cell engagement in IRI is clearly a nonclassical concept. We hypothesized that the TCR was directly involved in the pathogenesis of kidney IRI. We evaluated the response to kidney IRI in mice deficient in TCR ab or TCR gd T cells. We found that TCR ab-deficient mice had a significant functional and structural protection from kidney IRI, which in turn was associated with a decreased level of tumor necrosis factor (TNF)-a and interleukin (IL)-6 proteins in postischemic kidney tissue compared with wildtype (WT) mice, but not neutrophil and macrophage infiltration. TCR gd-deficient mice had a structural protection from IRI, and had a slight but not statistically significant functional protection as well. Thus, the TCR plays a direct but moderate role in the full expression of postischemic kidney damage.
Renal dysfunction after IRI
There were no statistically significant differences in the serum creatinine (SCr) between groups before IRI or sham surgery. At 24 h after IRI, TCR ab-deficient mice had significantly lower SCr than WT mice (*Po0.05). TCR gd-deficient mice showed a slight but not significant decrease in SCr compared to WT mice ( Figure 2 ).
TCR receptor expression
Flow cytometry was used to confirm the deficiency of TCR ab or TCR gd among CD3-positive T cells (Figure 3 ). The number of gated TCR ab-and gd-specific T cells in the corresponding genetically modified mice were less than 1%.
Tubular injury scoring of TCR-deficient mice
SCr is a useful but imperfect marker of kidney function. It does not gauge the effect of injury or an intervention on different regions in the kidney, but total function. In order to more carefully understand the effects of the TCR, we have semiquantitatively dissected histologic responses to kidney IRI in both WT and TCR knockout mice. Of importance is that the scoring was performed in a blinded fashion by an expert renal pathologist. Hematoxylin/eosin (H&E)-stained postischemia kidney tissue was scored to determine the severity of tubular injury. At 24 h after IRI, kidneys were characterized by extensive damage with prominent tubular necrosis and tubular dilation. There was vascular congestion in peritubular capillaries of the outer medulla, as well as some glomerular congestion. Renal injury was generalized rather than patchy (Figure 4 ). TCR ab-and gd-deficient mice had significantly decreased tubular injury, which was also found when quantified by a blinded expert pathology reviewer ( Figure 5 ). However, vascular congestion was similar in the different groups.
Leukocyte infiltration of kidney tissue after IRI
Leukocytes and other cells with phagocytic activity are important mediators of inflammation and renal injury after ischemia/reperfusion. It was shown that the myeloperoxidase (MPO) assay measures neutrophil infiltration and also detects macrophages. 7 We used the MPO assay in this study as a measure of both neutrophil and macrophage infiltration. MPO analysis of kidney homogenates revealed no differences in neutrophil and macrophage infiltration (P40.05) at 24 h after experimental IRI ( Figure 6 ) between WT, TCR ab-, and gd-deficient mice (0.03970.004, 0.04770.002, and 0.03970.002 absorbance (abs)/min/mg, respectively).
Kidney cytokine profile
Cytokines are potential effector molecules that modulate and regulate immune responses. There was a large increase in TNF-a in kidney tissue after IRI in all groups, but not in the sham-operated animals ( Figure 7a ). TNF-a concentration in WT animals was almost 6.5 times higher compared to normal levels, and four times higher than after sham surgery. In TCR-deficient mice, IRI also led to an elevation of TNF-a in kidney tissue, but this was blunted. Significant differences between TNF-a in WT and TCR ab-deficient mice were also observed (Po0.05). Statistically significant changes in IL-6 concentration after IRI between groups were also found between WT and TCR ab-deficient mice (Figure 7b ). We did not find any statistically significant differences among any groups in IL-1b concentration after IRI or sham surgery (Figure 7c ). Concentration of IL-2 decreased in WT and both types of TCR-deficient mice, but not after sham surgery (Figure 7d) , which was unexpected. RANTES was elevated in all operated animals without differences between them, and probably responded to anesthesia and surgical induced stress rather than kidney IRI (Figure 7f ). The same pattern was noted in interferon (IFN) g concentration ( Figure 7e ).
DISCUSSION
In the last few decades, there have been significant data demonstrating the participation of T cells in classically 'nonimmune' responses such as IRI, burns, trauma, and sepsis. 14 An important current area of investigation is the mechanisms by which T cells mediate IRI. It is unknown if T-cell engagement in IRI involves the more 'classic' signal 1 pathways mediated through the TCR. The present data demonstrate that TCR ab-deficient mice have improved survival, decreased renal dysfunction, and tubular injury after IRI compared to WT littermate strain-and sex-matched mice. TCR gd-deficient mice also have a slightly reduced mortality, renal dysfunction, and structural injury compared to WT, but not as marked as TCR ab-deficient mice. The acute tubular necrosis (ATN) regional scoring demonstrates reduced tubular injury in convoluted tubules, the straight segment of the cortex, and inner stripe of medulla in TCR ab-and gd-deficient mice compared to WT. This is consistent with the decrease in mortality and relative decrease in rise in SCr. The more marked protection in the inner stripe of the TCR ab-deficient mice could be important in explaining why this strain was more protected than the TCR gd-deficient strain. The apparent dissociation in histology and function is likely indicating that changes in SCr do not precisely reflect changes in kidney structure. After severe warm I/R renal injury, a pronounced acute tubular injury occurs during the first 12-24 h with an increase in renal MPO activity, reflecting the infiltration of activation of polymorphonuclear cells and macrophages. 7 We did not observe a difference in MPO level between groups to potentially invoke phagocyte trafficking changes as the potential mechanism underlying the TCR effect. However, we cannot exclude that more in-depth studies of MPO levels at different time points postischemia would have revealed a more subtle change in the kinetics of the MPO increase. Postischemic proinflammatory cytokine expression revealed an attenuated rise in TNF-a and IL-6 in TCR-deficient mice, which suggests that these cytokines are potential mediators of the TCR-mediated IRI.
ab T cells are subdivided into two distinct nonoverlapping populations, one that expresses CD4 and the other CD8. Thus, TCR ab-deficient mice are also CD4/CD8 deficient. The current data are consistent with previously published data on CD4/CD8 deficiency, conferring functional, and structural protection from renal IRI. 4 Furthermore, in vivo depletion of T cells in WT mice was protective in IRI of the kidney. 15 Reconstitution of T-cell-deficient athymic nu/nu mice with WT T cells restored postischemic injury. 5 gd T cells are frequently found in mucosal epithelium, but form only a minor population of circulating T-cell subsets. These cells do not express CD4 or CD8. We found that deficiency of gd T cells conferred a structural protection from renal IRI similar to ab deficiency; however, there was less protection in terms of functional changes, attenuation of TNF-a and IL-6 increase, and mortality.
Few T cells infiltrate into mouse kidney at 24 h after IRI; thus, T cells are likely orchestrating their effect through other pathways rather than being the final mediators of kidney dysfunction and tubular necrosis. 5 It was shown that blocking the costimulatory pathway by CTLA-4 immunoglobulin, reactive with both B7-1 and B7-2 costimulatory molecules, protects the kidney during acute ischemia/ reperfusion injury. As soon as 2 h after reperfusion, B7-1 was expressed along the endothelial cells of the ascending vasa recta and expression of B7-1 increased over time during the first 24 h and adherence/accumulation of T cells and monocytes/macrophages was found in the vasa recta of the ischemic kidney. 16 Thus, IRI involves early T-cell congestion of the capillaries, which could then facilitate congestion by other inflammatory cells. 16 We did not observe a difference in vascular congestion between our experimental groups using detailed light microscopy analysis, but more in-depth studies using special techniques in the future could reveal key differences. We found that TNF-a protein levels increased after IRI in WT mice, and this increase was blunted in TCRdeficient mice. TNF-a has been found to be upregulated after IRI [17] [18] [19] and TNF-a neutralization also inhibits ischemiainduced renal tubular cell apoptosis. 20, 21 Thus, our current data in the context of that of other groups suggest that TNF-a production could be a downstream effector of the TCR's role in IRI. IL-6 has also been invoked in kidney IRI injury, 22 is likely important, but not studied in depth so far. The attenuated IL-6 increase in the TCR ab knockouts compared to WT mice postischemia could also have played a relative protection seen in the TCR-deficient mice. Levels of IL-1 protein in kidney tended to decrease uniformly after ischemia in WT mice as well as in the TCR-deficient mice. Contrary to our expectations, IL-2 and IFN g protein levels decreased in postischemic kidney in all groups compared to normal or sham-operated mice. Studies investigating postischemic IL-2 levels have been controversial, with varying levels of IL-2 measured. Some studies have found a high expression 23 compared to studies showing minimally increased or even undetectable levels postischemia. 17 This may reflect differences in the model or detection techniques used. The drop in IL-2 levels in the kidney tissue in both TCR-deficient mice and in WT was studied with an 'n' of 6 per group and then was confirmed with an 'n' of 10 per group, but did not reach statistical significance. Thus, we are confident of these data. The mechanisms of the trend for a decrease in IL-2 proteins in both WT and TCR-deficient mice kidneys remain unclear and are beyond the scope and goals of the current study. RANTES levels also decreased, in contrast to a greater than 10-fold increase at 6 weeks postischemia. 24 We note that the effects of the TCR deficiency are not as profound as total T-cell absence, as published previously. 5 Ischemic ARF involves alterations in renal perfusion, continued hypoxia and inflammatory processes, all of which contribute to continued tubular cell injury. 25 However, we did find a protection in mortality, renal function, histology, and generation in TNF and IL-6 in TCR-deficient mice, particularly TCR ab-deficient mice. Clinically, even a modest (e.g. 10% protection) kidney function is sufficient to maintain survival off dialysis. Thus, even the mechanisms and therapies for modest changes are important.
In a number of published studies from our group, 5 T-cell reconstitution leads to enhanced tissue injury in ARF. A recently published paper 26 demonstrates similar effects on murine ARF if T-cell costimulation is blocked in a sepsis model of ARF, and T-cell repletion increases the injury responses.
The current data identify TCR as one of the pathophysiological mediators of kidney IRI. This implicates the early engagement of signal 1 (TCR-HLA) in kidney IRI, despite IRI being a classically 'nonimmune' disease lacking alloantigen. Further dissection of signal 1 pathways in IRI will assist in elucidating the mechanisms by which T cells modulate IRI in kidney and other organs. Identification of a role for TCR in kidney IRI could also lead to new therapies for this common and lethal disease.
MATERIALS AND METHODS
Mice TCR ab-(B6.129P2-Tcrbtm1Mom), TCR gd-deficient mice (B6.129P2-Tcrdtm1Mom), and background-strain matched WT littermates were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). Mice deficient in TCR ab have normal differentiation of gd thymocytes. 27 TCR gd-deficient mice have normal development of the ab T-cell lineage. Patterns of CD4 þ CD8À and CD4ÀCD8 þ ab T cells are apparently normal in the TCR gd-deficient mice. 28 Mice were housed under pathogenfree conditions, according to NIH guidelines. All studies conducted have been reviewed and approved by the John Hopkins animal care and use committee. To confirm TCR deficiency status, spleens, and lymph nodes from each group of mice were collected upon killing and analyzed using flow-cytometric analysis.
Renal ischemia-reperfusion model An established model of renal IRI was used. 29 Animals were anesthetized with 75 mg/kg intraperitoneal sodium pentobarbital. Under aseptic conditions, abdominal incisions were made, and the renal pedicles were bluntly dissected. A microvascular clamp was placed on both renal pedicles for 30 min, a well-characterized ischemia time. During surgery, animals were well hydrated with saline and kept at a constant temperature (B371C). After the clamps were removed, the wounds were sutured and the animals were allowed to recover.
Assessment of postischemic renal function
Blood samples were obtained from the tail vein at 0 and 24 h after ischemia. SCr (mg/dl) was measured on a Roche Cobas Fara automated system (Roche, Nutley, NJ, USA) using a Creatinine 557 kit (Sigma Diagnostics, St Louis, MO, USA).
Tissue histological examination
At 24 h after ischemia, kidneys were dissected from mice, and coronal tissue slices were fixed in 10% formalin and processed for histological examination using standard techniques. Formalin-fixed tissue was embedded in paraffin and 4-mm sections were cut. H&E-stained sections were examined in a blinded fashion by a pathologist to evaluate the degree of tubular necrosis. The magnitude of cell loss and necrosis was scored based on five levels. Scores ranged from 0 to 4 based on the percentage of tubules affected (0: o10%; 1: 10-25%; 2: 25-50%; 3: 50-75%; 4: 475%).
Flow-cytometric analysis
Postischemic spleens were crushed in 5 ml of Hank's balanced salt solution (HBSS)-2 using five strokes in a glass homogenizer. Cells were collected by centrifugation at 250 g for 10 min. They were then resuspended in ammonium chloride/potassium buffer for 5 min to remove red blood cells. Cells were washed three times with ice-cold HBSS-2 and filtered through a 70-mm nylon screen to remove debris. For each analysis, 10 6 cells were treated with an Fc block for 5 min, and then stained with 0.5 mg R-PE rat anti-mouse CD3e antibody (Ab) and fluorescein isothiocyanate (FITC)-conjugated anti-mouse TCR b and g Abs or isotype controls (PharMingen, San Diego, CA, USA) for 1 h on ice. Cells were then washed twice, fixed in 1% formalin, and analyzed on an Epics XL flow cytometer using System II software (Beckman Coulter, Fullerton, CA, USA).
Leukocyte detection using MPO assay Leukocyte (phagocyte) infiltration was measured in mouse kidney tissue 24 h after IRI.
Kidney samples were homogenized (1:20 wt/vol) in ice-cold KPO 4 buffer. Homogenate samples were spun at 17 000 g for 30 min at 41C, and pellets were washed and spun an additional two times. Then, 0.5% hexadecyltrimethylammonium bromide-10 mM EDTA was added to the remaining pellet (6:1). Suspensions were sonicated and freeze-thawed three times and then incubated at 41C for 20 min. After final centrifugation at 17 000 g at 41C for 15 min and addition of assay buffer (4:1), supernatants were measured for MPO. Change in absorbance over 3.5 min was recorded at 460 nm. One unit of MPO was defined as a change of absorbance of 1/min. Results were expressed as abs/min/100 mg of wet tissue that was detected using a bicinchoninic assay (Pierce Chemical, Rockport, IL, USA).
Measurement of cytokines level in kidney tissue
Weighed kidney samples containing 500 mg/ml of protein per sample (measured by bicinchoninic acid (BCA) (Pierce Chemical Co, Rockford, IL, USA) as per the manufacturer's instructions) were homogenized with cell lysis buffer (Cell Lysis Kit, Bio-Rad Laboratories Inc., Hercules, CA, USA). Tissue homogenates were centrifuged at 12 000 r.p.m. for 15 min at 41C and supernatants collected and used for the cytokine multiplex (IL-1b, IL-2, IL-6, IFN-g, TNF-a, and RANTES) bead-based immunoassay kit (BioRad Laboratories Inc., Hercules, CA, USA). Cytokine assay plate layout consisted of eight standards in duplicate (32 000-1.95 pg/ml), two blank wells (for background fluorescence subtraction), and each sample in duplicate wells. The cytokine multiplex assay uses a microbead and flow-based protein detection system (Bio-Plex Suspension Array System, Bio-Rad Laboratories Inc., Hercules, CA, USA) based on the Luminex xMAP technology. In this quantitative assay, surfaces of fluorescence-coded microbeads are conjugated to specific Abs directed against each cytokine or chemokine. Each fluorescence-coded microbead type is conjugated to one specific capture Ab, and consequently one specific target analyte. Each supernatant sample was first incubated with a mixture of all microbead types for 90 min at room temperature. Samples were then washed, incubated with a mixture of secondary biotinylated detection Abs also directed against each target for 30 min at room temperature, washed again, and incubated with a streptavidin-coupled phycoerythrin reporter system for 10 min at room temperature. After a final wash, the samples were resuspended in buffer and subjected to flow-cytometric analysis. The Bio-Plex system instrument uses fluidics, laser excitation, fluorescence detection, and digital signal processing for individual scanning and microbead identification. Each bead taken from the sample was identified based on its internal fluorescence signature, and the phycoerythrin reporter signal associated with that bead was quantified. The data were analyzed using Bio-Plex Manager TM 3.0 software (Bio-Rad Laboratories Inc., Hercules, CA, USA).
Statistical analysis
The experimental data were expressed as mean value7s.e. Differences between the groups were tested by unpaired Student's t-test and Po0.05 was considered to be statistically significant.
